Insider Trading History of Dave Kaushik J

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Dave Kaushik J since 2013. The trader's CIK number is 1522751. At the time of the last reporting, Dave Kaushik J was the Executive Vice President of Actinium Pharmaceuticals, Inc.. (stock ticker symbol ATNM). Also see all insider trading activities at Actinium Pharmaceuticals, Inc..

Note that in the past DAVE KAUSHIK J also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Actinium Pharmaceuticals, Inc. (ATNM) by Dave Kaushik J

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2016 ATNM 10,000 $20,150 0 $0 0 $0

Yearly summary of insider trading at Antares Pharma, Inc. (ATRS) by Dave Kaushik J

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2013 ATRS 0 $0 60,000 $240,767 60,000 $28,200


Insider trading activities at 2 companies by Dave Kaushik J:

1. Actinium Pharmaceuticals, Inc. (ATNM)

2. Antares Pharma, Inc. (ATRS)

Table 1. Insider trading of Actinium Pharmaceuticals, Inc. (ATNM) by Dave Kaushik J

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2016-04-14 ATNM Buy 10,000 2.02 20,150

Table 2. Insider trading of Antares Pharma, Inc. (ATRS) by Dave Kaushik J

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2013-06-03 ATRS Sale 48,000 4.01 192,528
2013-06-03 ATRS Option Ex 48,000 .47 22,560
2013-05-06 ATRS Sale 12,000 4.02 48,239
2013-05-06 ATRS Option Ex 12,000 .47 5,640

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Dave Kaushik J (Executive Vice President of Actinium Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.